Statement issued by the company (Announcement)<\/p>\n
The 2026 Sabin Awards<\/strong> were presented yesterday at the National Academy of Sciences building in Washington, D.C., with Professor U\u011fur \u015eahin<\/strong>, MD, and Professor \u00d6zlem T\u00fcreci, MD, receiving the Sabin Vaccine Institute\u2019s Albert B. Sabin Gold Medal<\/strong> for their role in turning the tide of the COVID-19 pandemic and their efforts to support access to novel medicines globally. Dr. Senjuti Saha<\/strong> of Bangladesh was awarded the 2026 Rising Star Award<\/strong> for using genomics to inform the rollout of the world\u2019s largest typhoid vaccine program, protecting millions of children.<\/p>\n \u201cTogether, Professors \u015eahin and T\u00fcreci have helped reshape the future of vaccines, demonstrating how scientific entrepreneurship can translate cutting-edge research into global public health impact,\u201d said Sabin Chief Executive Officer Amy Finan<\/strong>. \u201cThe Sabin Gold Medal recognizes their extraordinary contribution for accelerating lifesaving vaccines and their commitment to vaccine access and equity.\u201d<\/p>\n Professors \u015eahin<\/strong> and T\u00fcreci<\/strong>, who are both business and life partners, were awarded the Sabin Gold Medal for their steadfast dedication to supporting medicine access through innovative technologies they have been pioneering for decades. At the onset of the COVID-19 pandemic, they leveraged the technology they had been researching and developing for decades originally for oncology applications and pivoted their company\u2019s focus to develop a COVID-19 vaccine in record time that helped protect billions of lives.<\/p>\n Driven by the mission to improve the health of people worldwide, \u015eahin and T\u00fcreci continue to advance the development of vaccine candidates against diseases of major relevance to millions of people worldwide, including tuberculosis, HIV, and malaria. Their dedication extends beyond developing medical innovations as they work along the entire R&D chain to make a difference for communities. Together with their team and partners, they are leading efforts to contribute to build a sustainable and resilient vaccine ecosystem in Africa, for Africa.<\/p>\n \u201cWe are deeply honored to receive the 2026 Sabin Gold Medal. Albert Sabin\u2019s conviction that scientific breakthroughs only truly matter when they reach the people has been a lasting source of inspiration for us. We firmly believe that innovative medicines must be accessible to those who need them most,\u201d said Professors \u015eahin and T\u00fcreci. \u201cThis award is a testament to a collaborative effort, recognizing the dedication of our teams and partners around the world who walk this journey with us and share a deep sense of commitment to improving health.\u201d<\/p>\n Sabin\u2019s Rising Star Award<\/strong> encourages and recognizes the next generation of vaccine and immunization leaders. Rising Star Awardee Dr. Senjuti Saha generates critical evidence for major national immunization initiatives, including Bangladesh\u2019s 2025 typhoid conjugate vaccine campaign that has already reached more than 40 million children. As Deputy Executive Director of the Child Health Research Foundation (CHRF), she helped build one of the country\u2019s leading genomic laboratories. The lab has sequenced thousands of pathogen genomes to improve outbreak detection and inform vaccine development for diseases such as Klebsiella and RSV. Her work also emphasizes developing local scientific leadership and mentoring the next generation of researchers.<\/p>\n \u201cThis award is incredibly meaningful to me because it reflects years of work by an extraordinary community in Bangladesh and shows that great science can grow anywhere people are determined to solve problems together,\u201d said Dr. Saha.<\/p>\n \u201cDr. Senjuti Saha exemplifies the next generation of scientific leadership,\u201d said Finan. \u201cShe understands that her work doesn\u2019t stop in the laboratory or with a published paper. To improve and protect community health, she uses data and evidence to advocate for strong vaccine policy.\u201d<\/p>\n The Albert B. Sabin Gold Medal and Rising Star Award, awarded since 1994 and 2020 respectively, celebrate Dr. Sabin\u2019s legacy of ensuring vaccine access for all. They honor individuals who have made extraordinary contributions to immunization and global health. These awards commemorate the legacy of the late Dr. Albert B. Sabin, who discovered the oral polio vaccine and dedicated his life to ensuring everyone in the world had access to vaccines.<\/p>\n Watch the 2026 Sabin Awards ceremony recording<\/a>.<\/p>\n The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org<\/a> and follow us on LinkedIn.<\/p>\nAbout the Sabin Vaccine Institute<\/h2>\n
Media Contact:<\/strong>\r\nMonika Guttman\r\nSenior Manager, Digital Communications and Media\r\nSabin Vaccine Institute\r\n+1 (202) 621-1691\r\npress@sabin.org<\/a><\/pre>\n